Christopher R. Aker
2020
In 2020, Christopher R. Aker earned a total compensation of $809.1K as SVP & General Counsel at Regulus Therapeutics, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,300 |
|---|---|
| Option Awards | $351,646 |
| Salary | $315,000 |
| Other | $10,172 |
| Total | $809,118 |
Aker received $351.6K in option awards, accounting for 43% of the total pay in 2020.
Aker also received $132.3K in non-equity incentive plan, $315K in salary and $10.2K in other compensation.
Rankings
In 2020, Christopher R. Aker's compensation ranked 9,457th out of 13,090 executives tracked by ExecPay. In other words, Aker earned more than 27.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,457 out of 13,090 | 28th |
Division Manufacturing | 4,051 out of 5,621 | 28th |
Major group Chemicals And Allied Products | 1,647 out of 2,254 | 27th |
Industry group Drugs | 1,443 out of 1,954 | 26th |
Industry Pharmaceutical Preparations | 1,060 out of 1,459 | 27th |
Source: SEC filing on April 30, 2021.
Aker's colleagues
We found two more compensation records of executives who worked with Christopher R. Aker at Regulus Therapeutics in 2020.